Cetera Investment Advisers
IDYA icon

Cetera Investment Advisers’s IDEAYA Biosciences IDYA Stock Holding History

Cetera Investment Advisers’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Buy
20,772
+1,909
+10% +$58.4K ﹤0.01% 3277
2026
Q1 		$629K Sell
18,863
-5,760
-23% -$193K ﹤0.01% 3305
2025
Q4 		$851K Buy
24,623
+3,719
+18% +$119K ﹤0.01% 2968
2025
Q3 		$569K Buy
+20,904
New +$506K ﹤0.01% 3274

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Cetera Investment Advisers's IDYA Position: Q2 2026 in Review

Cetera Investment Advisers increased its IDEAYA Biosciences (IDYA) stake by 10% in Q2 2026, buying an estimated $58.4K and bringing the position to 20,772 shares worth $774K. The position accounts for ﹤0.01% of the portfolio, ranked #3277.

Cetera Investment Advisers first reported a position in IDYA in Q3 2025 and has held it in 4 quarters since. The position peaked at $851K in Q4 2025. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Cetera Investment Advisers held 20,772 shares of IDEAYA Biosciences worth $774K as of Q2 2026.
  • Cetera Investment Advisers bought 1,909 IDEAYA Biosciences shares in Q2 2026, an estimated $58.4K.
  • IDEAYA Biosciences made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3277 holding.
  • Cetera Investment Advisers first reported a position in IDEAYA Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Cetera Investment Advisers's IDEAYA Biosciences position peaked at $851K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.